Long-Term Follow-up after a Drug Trial for Panic Disorder
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background: This study investigates the naturalistic course of panic disorder over four years and attempts to identify predictors for outcome. Method: 423 DSM–III–R panic disorder patients who had taken part in an international multicentre drug trial were selected for follow-up; we were able to re-interview 367 (87%). For panic attacks, phobic avoidance and disabilities the same rating scales were administered as had been used for the clinical trials. Results: While 61 % of all patients experienced at least occasional panic attacks at follow-up, few suffered from serious phobic avoidance (16.7%) or serious disabilities (work 7.9%; family 8.7%; social 13.9%). Panic attack frequency at baseline, original trial medication and continuous use of psychotropic medication during follow-up are not related to outcome, whereas longer duration of illness and more severe phobic avoidance at baseline are unfavourable. Conclusion: The course of panic disorder is not uniform. Since long duration of illness and severe phobic avoidance at baseline are predictors for an unfavourable outcome, more rigorous efforts should be undertaken to detect and treat panic disorder at an early stage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clark, D. M. (1986) · Behaviour Research and Therapy · doi:10.1016/0005-7967(86)90011-2 · Cited by 2,422 · cited 1×
“Thus it is possible that what are formulated as therapeutic principles by behaviour therapists (Marks, 1981) and cognitive therapists (Clark, 1986) might have worked unintentionally during the original drug trials, and then continued to work.”
BackgroundClark, D. M., Salkovskis, P. M., Hackmann, A., Middleton, H., Anastasiades, P., & Gelder, M. (1994) · British Journal of Psychiatry · doi:10.1192/bjp.164.6.759 · Cited by 673
Ballenger, J. C. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800290027004 · Cited by 564
Cited by
Bruce, S. E., Yonkers, K. A., Otto, M. W., Eisen, J. L., Weisberg, R. B., Pagano, M., Shea, M. T., & Keller, M. B. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.6.1179 · Cited by 963
Steinert, C., Hofmann, M., Leichsenring, F., & Kruse, J. (2013) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2013.08.002 · Cited by 88
Subclinical Symptoms of Panic Disorder: New Insights into Pathophysiology and Treatment
Fava, G. A., & Mangelli, L. (1999) · Psychotherapy and Psychosomatics · doi:10.1159/000012345 · Cited by 62
White, K. S., Payne, L. A., Gorman, J. M., Shear, M. K., Woods, S. W., Saksa, J. R., & Barlow, D. H. (2013) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0030666 · Cited by 42
“The clinical course of PD has been characterized as chronic, with high rates of relapse, particularly for women (Katschnig et al., 1995; Keller et al., 1994; Yonkers, Bruce, Dyck, & Keller, 2003).”
Moylan, S., Staples, J., Ward, S. A., Rogerson, J., Stein, D. J., & Berk, M. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31822d0012 · Cited by 34
A dose-finding and discontinuation study of clomipramine in panic disorder
Lotufo-Neto, F., Bernik, M., Ramos, R. T., Andrade, L., Gorenstein, C., Cordás, T., Melo, M., & Gentil, V. (2001) · Journal of Psychopharmacology · doi:10.1177/026988110101500103 · Cited by 27
Payne, L. A., White, K. S., Gallagher, M. W., Woods, S. W., Shear, M. K., Gorman, J. M., Farchione, T. J., & Barlow, D. H. (2016) · Depression and Anxiety · doi:10.1002/da.22457 · Cited by 13
Metadata
- Authors
- Katschnig, H., Amering, M., Stolk, J. M., Klerman, G. L., Ballenger, J. C., Briggs, A., Buller, R., Cassano, G., Garvey, M., Roth, S. M., & Solyom, C.
- Venue
- British Journal of Psychiatry
- Publisher
- Royal College of Psychiatrists
- Published
- 1995-10
- Volume
- 167
- Issue
- 4
- Pages
- 487-494
- ISSN
- 0007-1250 (ISSN-L)
- 1472-1465
- OpenAlex
- W1980152291
- Cited by
- 60
- References
- 3
- FWCI
- 7.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.